DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
|Docket||⤷ Try it Free||Date Filed||2018-03-08|
|Court||District Court, D. Delaware||Date Terminated||2019-02-06|
|Cause||35:271 Patent Infringement||Assigned To||Leonard Philip Stark|
|Jury Demand||None||Referred To|
|Patents||6,956,041; 6,965,027; 7,091,208; 7,265,221; 7,301,023; RE41,783|
|Link to Docket||External link to docket|
Small Molecule Drugs cited in Pfizer Inc. v. Prinston Pharmaceutical Inc.
Biologic Drugs cited in Pfizer Inc. v. Prinston Pharmaceutical Inc.
|Date Filed||Document No.||Description||Snippet||Link To Document|
|2018-03-08||1||additional patents for Xeljanz® that are not a subject of this Complaint : U.S. Patent Nos. 6,956,041 (expiring…infringement of United States Reissue Patent No. RE41,783 (the “’783 patent”). 2. This action arises…, 2017, addressed U.S. Patent Nos. 6,965,027 and 7,301,023, and those patents are at issue in Civil Action…. The ’783 Patent 24. On September 28, 2010, the USPTO issued the ’783 patent, titled “Pyrrolo…pyrimidine Compounds.” The ’783 patent is a reissue of U.S. Patent No. 6,627,754, which issued on September||External link to document|
|2018-03-08||4||the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,783 E. (crb) (Entered: …2018 7 February 2019 1:18-cv-00380 835 Patent - Abbreviated New Drug Application(ANDA) None||External link to document|
|>Date Filed||>Document No.||>Description||>Snippet||>Link To Document|